Literature DB >> 34649945

Perspective on Fibroblast Activation Protein-Specific PET/CT in Fibrotic Interstitial Lung Diseases: Imaging Fibrosis-A New Paradigm for Molecular Imaging?

Christian Schmidkonz1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34649945      PMCID： PMC8717189          DOI： 10.2967/jnumed.121.262944

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   11.082


× No keyword cloud information.
  9 in total

1.  Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging.

Authors:  Christian Schmidkonz; Simon Rauber; Armin Atzinger; Rahul Agarwal; Theresa Ida Götz; Alina Soare; Michael Cordes; Olaf Prante; Christina Bergmann; Arnd Kleyer; Philipp Ritt; Simone Maschauer; Peter Hennig; Johannes Toms; Markus Köhner; Bernhard Manger; John H Stone; Uwe Haberkorn; Tobias Baeuerle; Jörg H W Distler; Abbas Agaimy; Torsten Kuwert; Georg Schett; Andreas Ramming
Journal:  Ann Rheum Dis       Date:  2020-07-21       Impact factor: 19.103

2.  Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.

Authors:  Thomas Lindner; Anastasia Loktev; Annette Altmann; Frederik Giesel; Clemens Kratochwil; Jürgen Debus; Dirk Jäger; Walter Mier; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2018-04-06       Impact factor: 10.057

Review 3.  Interstitial lung disease in systemic sclerosis: current and future treatment.

Authors:  Roberto Giacomelli; Vasiliki Liakouli; Onorina Berardicurti; Piero Ruscitti; Paola Di Benedetto; Francesco Carubbi; Giuliana Guggino; Salvatore Di Bartolomeo; Francesco Ciccia; Giovanni Triolo; Paola Cipriani
Journal:  Rheumatol Int       Date:  2017-01-06       Impact factor: 2.631

4.  Luciferase expression is driven by the promoter of fibroblast activation protein-α in murine pulmonary fibrosis.

Authors:  Li Wenlong; Yang Leilei; Fan Wei; Chen Yi; Tian Jing; Ma Lanzhi; Liu Bing; Li Yang; Wang Shaoxia; Fu Qiuxia; Chen Zeliang; Zhao Zengming
Journal:  Biotechnol Lett       Date:  2015-05-21       Impact factor: 2.461

Review 5.  Systemic sclerosis-associated interstitial lung disease.

Authors:  Apostolos Perelas; Richard M Silver; Andrea V Arrossi; Kristin B Highland
Journal:  Lancet Respir Med       Date:  2020-02-20       Impact factor: 30.700

Review 6.  Quantification of Lung PET Images: Challenges and Opportunities.

Authors:  Delphine L Chen; Joseph Cheriyan; Edwin R Chilvers; Gourab Choudhury; Christopher Coello; Martin Connell; Marie Fisk; Ashley M Groves; Roger N Gunn; Beverley F Holman; Brian F Hutton; Sarah Lee; William MacNee; Divya Mohan; David Parr; Deepak Subramanian; Ruth Tal-Singer; Kris Thielemans; Edwin J R van Beek; Laurence Vass; Jeremy W Wellen; Ian Wilkinson; Frederick J Wilson
Journal:  J Nucl Med       Date:  2017-01-12       Impact factor: 10.057

Review 7.  Shared and distinct mechanisms of fibrosis.

Authors:  Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2019-11-11       Impact factor: 20.543

8.  Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.

Authors:  Benjamin Bondue; Amélie Castiaux; Gaetan Van Simaeys; Céline Mathey; Félicie Sherer; Dominique Egrise; Simon Lacroix; François Huaux; Gilles Doumont; Serge Goldman
Journal:  Respir Res       Date:  2019-01-15

9.  Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study.

Authors:  Manuel Röhrich; Dominik Leitz; Frederik M Glatting; Annika K Wefers; Oliver Weinheimer; Paul Flechsig; Nicolas Kahn; Marcus A Mall; Frederik L Giesel; Clemens Kratochwil; Peter E Huber; Andreas von Deimling; Claus Peter Heußel; Hans Ulrich Kauczor; Michael Kreuter; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2021-07-16       Impact factor: 11.082
  9 in total
  1 in total

1.  Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy.

Authors:  Sebastian E Serfling; Philipp E Hartrampf; Yingjun Zhi; Takahiro Higuchi; Steven P Rowe; Lena Bundschuh; Markus Essler; Andreas K Buck; Ralph Alexander Bundschuh; Rudolf A Werner
Journal:  Clin Nucl Med       Date:  2022-04-19       Impact factor: 10.782
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.